Meisner Lara sold BCAX

March 14, 2025 · Form 4 insider transaction

Meisner Lara sold 48,720 shares of Bicara Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
48,720
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeM: Option exercise
Transaction dateMarch 14, 2025
Filing dateMarch 18, 2025
Shares owned after107,187
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.; 25% of the shares underlying this option vested on November 27, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

View the original Form 4 on SEC EDGAR